Shopping Cart
- Remove All
- Your shopping cart is currently empty
PF-06446846 hydrochloride, an orally active and highly selective inhibitor, targets Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) translation by inducing ribosomal stalling at approximately codon 34, effectively suppressing PCSK9 expression.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $91 | In Stock | |
5 mg | $226 | In Stock | |
10 mg | $363 | In Stock | |
25 mg | $593 | In Stock | |
50 mg | $848 | In Stock | |
100 mg | $1,170 | In Stock | |
500 mg | $2,330 | In Stock | |
1 mL x 10 mM (in DMSO) | $233 | 6-8 weeks |
Description | PF-06446846 hydrochloride, an orally active and highly selective inhibitor, targets Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) translation by inducing ribosomal stalling at approximately codon 34, effectively suppressing PCSK9 expression. |
In vitro | PF-06446846 suppresses the secretion of PCSK9 by Huh7 cells (IC50: 0.3 μM)[1]. |
In vivo | PF-06446846 (oral gavage; 5-50 mg/kg/day for 14 days) lowers plasma PCSK9 in a dose-dependent manner. It also decreases total cholesterol levels[1]. |
Formula | C22H20CIN7O.XHCl |
Cas No. | 1632250-50-0 |
Smiles | Cl.Clc1cccnc1N([C@@H]1CCCNC1)C(=O)c1ccc(cc1)-n1nnc2cccnc12 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O: 90.0 mg/mL (191.3 mM), Sonication is recommended. DMSO: 225.0 mg/mL (478.4 mM), Sonication is recommended. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.